focus
Previous article:
Cancer drug shortages should be causing more outrage
Next article: Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead
Next article: Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead
entertainment
hotspot
-
Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health
2025-10-02 20:32 -
Data integrity in scientific journals requires "effort" by publishers, institutions
2025-10-02 20:28 -
Medicare Advantage enrollment hits roughly 33.4 million
2025-10-02 20:27 -
Ukraine seeks to reclaim its role as a hub for clinical trials
2025-10-02 19:29 -
Researchers tackle phage therapy hurdles for wider adoption
2025-10-02 19:07 -
Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers
2025-10-02 18:49